Liquid Biopsy, Diagnostic Imaging, and Future Synergies

Area of Science:

• Oncology
• Radiology
• Molecular Diagnostics

Background:

• Medical imaging is crucial for cancer diagnosis and patient management.
• Liquid biopsies, analyzing circulating free DNA, offer a minimally invasive approach.
• Integrating these modalities can enhance cancer care across the continuum.

Purpose of the Study:

• To examine the role of liquid biopsies in non-small-cell lung cancer (NSCLC) care.
• To highlight how liquid biopsies are transforming clinical practice.
• To explore future collaborations between liquid biopsy and imaging.

Main Methods:

• Review of current literature on liquid biopsy and cancer imaging.
• Case studies focusing on non-small-cell lung cancer.
• Analysis of clinical practice changes and future potential.

Main Results:

• Liquid biopsies are increasingly vital in NSCLC diagnosis and monitoring.
• Synergies exist in early detection, screening, and treatment response assessment.
• Clinical practice is evolving to incorporate liquid biopsy alongside imaging.

Conclusions:

• Liquid biopsies are essential complementary tools in oncology.
• The integration of liquid biopsy and imaging promises improved cancer care.
• Future research should focus on optimizing combined diagnostic and monitoring strategies.